BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maitre M, Klein C, Mensah-Nyagan AG. A proposed preventive role for Gamma-hydroxybutyrate (Xyrem(R)) in Alzheimer's disease. Alzheimers Res Ther 2016;8:37. [PMID: 27601032 DOI: 10.1186/s13195-016-0205-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Roland JP, Bliwise DL. Impact of Pharmacotherapy on Insomnia in Patients with Alzheimer's Disease. Drugs Aging 2021;38:951-66. [PMID: 34569029 DOI: 10.1007/s40266-021-00891-1] [Reference Citation Analysis]
2 Voysey ZJ, Barker RA, Lazar AS. The Treatment of Sleep Dysfunction in Neurodegenerative Disorders. Neurotherapeutics 2021;18:202-16. [PMID: 33179197 DOI: 10.1007/s13311-020-00959-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
3 Ciminelli BM, Menduti G, Benussi L, Ghidoni R, Binetti G, Squitti R, Rongioletti M, Nica S, Novelletto A, Rossi L, Malaspina P. Polymorphic Genetic Markers of the GABA Catabolism Pathway in Alzheimer's Disease. J Alzheimers Dis 2020;77:301-11. [PMID: 32804142 DOI: 10.3233/JAD-200429] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Lucey BP, Hicks TJ, Elbert DL, Ovod V, Mawuenyega KG, Morris JC, Bateman RJ. Reply to "Excess amyloid beta can be degraded in healthy humans". Ann Neurol 2018;83:650-1. [PMID: 29457845 DOI: 10.1002/ana.25185] [Reference Citation Analysis]
5 Vogel KR, Ainslie GR, McConnell A, Roullet JB, Gibson KM. Toxicologic/transport properties of NCS-382, a γ-hydroxybutyrate (GHB) receptor ligand, in neuronal and epithelial cells: Therapeutic implications for SSADH deficiency, a GABA metabolic disorder. Toxicol In Vitro 2018;46:203-12. [PMID: 29031482 DOI: 10.1016/j.tiv.2017.10.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
6 Mamelak M. Energy and the Alzheimer brain. Neurosci Biobehav Rev 2017;75:297-313. [PMID: 28193453 DOI: 10.1016/j.neubiorev.2017.02.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]